Rebetol and Fatigue - a phase IV clinical study of FDA data

Summary:

Fatigue is found among people who take Rebetol, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Rebetol and have Fatigue. It is created by eHealthMe based on reports of 25,882 people who have side effects when taking Rebetol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 12, 2023

25,882 people reported to have side effects when taking Rebetol.
Among them, 2,064 people (7.97%) have Fatigue.

What is Rebetol?

Rebetol has active ingredients of ribavirin. eHealthMe is studying from 25,907 Rebetol users for its effectiveness, alternative drugs and more.

What is Fatigue?

Fatigue (feeling of tiredness) is found to be associated with 5,406 drugs and 6,184 conditions by eHealthMe.

Number of Rebetol and Fatigue reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Rebetol and have Fatigue?

Check whether Fatigue is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

Related studies

How severe was Fatigue and when was it recovered:

Fatigue in Rebetol

Expand to all the drugs that have ingredients of ribavirin:

Fatigue and drugs with ingredients of ribavirin (18,378 reports)

Alternative drugs to, pros and cons of Rebetol:

Rebetol (25,907 reports)

Common Rebetol side effects:

Fatigue (feeling of tiredness): 2,064 reports
Rashes (redness): 1,812 reports
Thrombocytopenia (decrease of platelets in blood): 1,709 reports
Fever: 1,629 reports
Weakness: 1,422 reports
Depression: 1,377 reports

Browse all side effects of Rebetol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Fatigue treatments and more:

Fatigue (814,940 reports)

COVID vaccines that are related to Fatigue:

Common drugs associated with Fatigue:

All the drugs that are associated with Fatigue:

Fatigue (5,406 drugs)

Common conditions associated with Fatigue:

All the conditions that are associated with Fatigue:

Fatigue (6,184 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin (the active ingredients of Rebetol) and Rebetol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.